Depedin Veyx
Depedin Veyx
Authorised
- Prednisolone acetate
- Dexamethasone
Product identification
Medicine name:
Depedin Veyx
Active substance:
- Prednisolone acetate
- Dexamethasone
Target species:
-
Dog
-
Cat
Route of administration:
-
Intradermal use
Product details
Active substance and strength:
-
Prednisolone acetate7.50/milligram(s)1.00millilitre(s)
-
Dexamethasone2.50/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Concentrate for suspension for injection
Withdrawal period by route of administration:
-
Intradermal use
- Dog
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QH02AB30
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Croatia
Available in:
-
Croatia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Veyx Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Veyx-Pharma B.V.
Responsible authority:
- Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
- UP/I-322-05/13-01/456
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Croatian (PDF)
Published on: 8/02/2022
How useful was this page?:
